Published in Clin Colorectal Cancer on July 01, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2007) 25.52
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 16.24
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet (2004) 11.37
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet (2010) 9.72
A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med (2011) 8.63
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet (2010) 8.41
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol (2007) 6.82
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65
Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol (2004) 5.44
Diabetic retinopathy. Lancet (2010) 5.38
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol (2009) 5.37
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med (2012) 5.31
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies. Am J Clin Nutr (2008) 5.07
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer (2006) 4.92
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol (2012) 4.91
The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol (2004) 4.64
The association of aspirin use with age-related macular degeneration. JAMA Intern Med (2013) 4.62
Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology (2008) 4.50
Age-related macular degeneration. Lancet (2012) 4.17
Outdoor activity reduces the prevalence of myopia in children. Ophthalmology (2008) 3.99
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol (2012) 3.86
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol (2011) 3.27
The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology (2010) 3.08
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology (2006) 2.87
Vision loss in Australia. Med J Aust (2005) 2.86
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol (2011) 2.84
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration. Am J Clin Nutr (2013) 2.75
Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet (2010) 2.75
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res (2003) 2.73
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncol (2013) 2.69
Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res (2008) 2.66
Clinical update: new treatments for age-related macular degeneration. Lancet (2007) 2.65
Hypertensive retinopathy. N Engl J Med (2004) 2.65
Macular and nerve fiber layer thickness in amblyopia: the Sydney Childhood Eye Study. Ophthalmology (2009) 2.64
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol (2014) 2.64
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol (2006) 2.59
Prevalence of mitochondrial 1555A-->G mutation in adults of European descent. N Engl J Med (2009) 2.57
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol (2003) 2.56
A systematic review of the effect of waiting for treatment for chronic pain. Pain (2007) 2.52
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust (2010) 2.44
Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet (2011) 2.42
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet (2007) 2.42
Improving vision to prevent falls in frail older people: a randomized trial. J Am Geriatr Soc (2007) 2.42
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Biological variation of glycohemoglobin. Clin Chem (2002) 2.38
Older drivers in Australia: trends in driving status and cognitive and visual impairment. J Am Geriatr Soc (2009) 2.37
Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
The eye in hypertension. Lancet (2007) 2.32
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology (2010) 2.27
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer (2011) 2.24
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Clin Cancer Res (2005) 2.24
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet (2006) 2.23
The effect of cataract surgery on neuropsychological test performance: a randomized controlled trial. J Int Neuropsychol Soc (2006) 2.22
Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18
Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology (2008) 2.11
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer (2011) 2.09
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Age-related macular degeneration and risk for stroke. Ann Intern Med (2006) 2.07
Intraocular pressure asymmetry and undiagnosed open-angle glaucoma in an older population. Am J Ophthalmol (2004) 2.07
Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol (2003) 2.04
Role of near work in myopia: findings in a sample of Australian school children. Invest Ophthalmol Vis Sci (2008) 2.04
Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol (2009) 2.01
Visual acuity and the causes of visual loss in a population-based sample of 6-year-old Australian children. Ophthalmology (2005) 1.98
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure. Oral Oncol (2012) 1.98
The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology (2010) 1.97
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97
Mitochondrial DNA haplogroups and age-related maculopathy. Arch Ophthalmol (2007) 1.90
Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology (2007) 1.90
Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens (2011) 1.89
Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol (2004) 1.88
Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology (2010) 1.88
Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol (2010) 1.87
Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol (2004) 1.86
Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology (2007) 1.86
EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet (2009) 1.82
Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol (2006) 1.81
Visual risk factors for hip fracture in older people. J Am Geriatr Soc (2003) 1.80
Refractive error and patterns of spectacle use in 12-year-old Australian children. Ophthalmology (2006) 1.80